PROTEON THERAPEUTICS INC - COM (PRTO)

CUSIP: 74371L109

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
7,215,921
Share change
+196,254
Total reported value
$12,524,000
Price per share
$1.75
Number of holders
27
Value change
+$340,667
Number of buys
15
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 74371L109?
CUSIP 74371L109 identifies PRTO - PROTEON THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTEON THERAPEUTICS INC - COM (PRTO) as of Q1 2017

As of 31 Mar 2017, PROTEON THERAPEUTICS INC - COM (PRTO) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,215,921 shares. The largest 10 holders included Abingworth LLP, DEERFIELD MANAGEMENT CO, Pharmstandard International S.A., MPM ASSET MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Deer VII & Co. Ltd., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, JACOBS LEVY EQUITY MANAGEMENT, INC, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.